Libsyn Directory

David McMullen of NIH on Blueprint Medtech, the program to help neurotech companies grow

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

Release Date: 08/30/2021

Sergey Young on lifespan and health span extension through his Longevity Fund

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is a longevity investor and visionary with a mission to extend healthy lifespans of at least one billion people. To do that, Sergey founded Longevity Vision Fund to accelerate life extension technological breakthroughs and to make longevity affordable and accessible to all Top 3 Takeaways: "I'm sponsoring the development of age reversal X price. This is a technological competition to basically reverse aging measured by a set of biomarkers." "Some of the companies that we have in our portfolio decrease the cost of a particular healthcare intervention or solution to a particular health...

Miguel Nicolelis on Neuralink and performing in front of a billion people at the 2014 World Cup

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

Although the is best known for pioneering studies in neuronal population coding, Brain-Machine Interfaces (BMI) and neuroprosthetics in human patients and non-human primates, they have also developed an integrative approach to studying neurological and psychiatric disorders including Parkinsons disease and epilepsy. Top 3 Takeaways: "Every Brazilian kid dreams to play for the Brazilian national team in a world cup game, I didn't quite fulfill the dream, but I got as close as a scientist can get. And we had about 65,000 people in the stadium that day in about 1.2 billion people watching the...

Kip Ludwig on some of the more controversial neurotech ideas

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

leads the Bioelectronic Medicines Laboratory at the , with the goal of developing next-generation neuromodulation therapies that use minimally invasive strategies to highjack the nervous system to treat circuit dysfunction and deliver biomolecules to target areas with unprecedented precision. Prior to Wisconsin, Dr. Ludwig served as the Program Director for Neural Engineering at the National Institutes of Health. He co-led the Translational Devices Program at NINDS, led the NIH BRAIN Initiative programs to catalyze implantable academic and clinical devices to stimulate and/or record from the...

Justin Sanchez on going from working at DARPA to helping roll out tech at Battelle

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is a Life Sciences Research Technical Fellow at but before that he was Director of Biological Technologies office at DARPA. Top 3 Takeaways "You'll never be able to establish your academic career unless you go and move to another place. I'm like, guys, this doesn't make any sense to me. What's most important is to do great work in the field and establish a foundation of the field." "I still had my university job for a couple of years while I was serving at DARPA. And if my time at DARPA and everybody's term-limited at DARPA. When that term ended, I could have gone back to Miami." "I...

Victor Pikov on starting a bioelectronic medicine company after working at Galvani

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is the founder and CEO of , a sacral nerve stimulation neuromodulation company and VP of Technology at TRI, Trans Stimulation Incorporated. He also worked at Galvani, a joint venture between Google and GSK as well as working in academia before. Top 3 Takeaways "When you try to speak to potential investors who consider themselves experts in medical devices, they typically fall into three categories: One is no experience with neuromodulation and another bucket is experienced with wearable neuromodulation. And the third very small bucket is experience with implantable class three...

Daniel Palanker on breaking physics to found neurotech companies

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is at Stanford University. He has had many successful technologies spun off into companies or patents including those involving retinal prosthetics, optical imaging and spectroscopy, laser-tissue interactions, and retinal plasticity. Top 3 Takeaways "The [size] limitation for a retinal prosthesis is not in a fabrication side. The limitation is an interface with neurons" Allergan acquired Oculeve but then didn't do much with it seemingly because they already had a more profitable drug on the market "Stanford is industry-friendly, encouraging commercialization, basically making things...

Donna Hamlin, an executive coach on how to be a better leader in neurotech

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is a corporate executive with thirty years of corporate, governance and strategy consulting experience. She oversees ’s global programs, including its centers and their services. These include: board evaluations, professional certification and training, its global registry of qualified directors, Board Bona Fide®, its strategic partnership programs and its Boardwise center. Top 3 Takeaways "It's really important to know that if we want to be good at our work, then we've got to explore things outside of our normal swim lanes. And when we do that, it gives us a different view or...

David McMullen of NIH on Blueprint Medtech, the program to help neurotech companies grow

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

is the program officer at the in the National Institutes of Health (NIH). They are launching the NIH Blueprint Medtech (links below) which aims to help incubate growing neurotech companies go from Bench to Bedside. Top 3 Takeaways "We're funding individual projects and trying to help groups in the past have struggled... to get funding and to get all the way to in human trials. The Blueprint Medtech resource is meant to derisk later investment and grants for companies "We saw some great programs... having difficulty when they come in - Can we decrease the activation...

Jon Speer on how Quality Management Software for Medtech companies raised $120 Million

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

Jon is the founder of (quality management software exclusively for medical device companies) & a medical device guru with nearly 20 years industry experience. Jon knows the best medical device companies in the world use quality as an accelerator. That's why he created Greenlight Guru to help companies move beyond compliance to True Quality. Top 3 Takeaways If it isn't documented, it didn't happen. One particular audit didn't take four days. It took two days because the Greenlight system made it so much simpler. Greenlight Guru also has an academy to teach people about the...

Dr Aldo Faisal on using eye movements and AI to improve BCIs

Neural Implant podcast - the people behind Brain-Machine Interface revolutions

Professor is the Professor of AI & Neuroscience at the Dept. of Computing and the Dept. of Bioengineering at Imperial College London. His work is in Machine Learning and eye tracking to improve neurotechnologies. Top 3 Takeaways "What we do is we get people to move into our living lab/studio flat and they live their daily lives, and we record everything that they do, how they do, where they look, we record the eye movements, the body movements, and everything." "The more subjects you add to your dataset from different datasets, the worse the performance of the system becomes." A...

More Episodes

David McMullen is the program officer at the National Institute of Mental Health (NIMH) in the National Institutes of Health (NIH). They are launching the NIH Blueprint Medtech (links below) which aims to help incubate growing neurotech companies go from Bench to Bedside.

Top 3 Takeaways

"We're funding individual projects and trying to help groups in the past have struggled... to get funding and to get all the way to in human trials.
The Blueprint Medtech resource is meant to derisk later investment and grants for companies
"We saw some great programs... having difficulty when they come in - Can we decrease the activation energy to getting to first-in-human? Can we compress the timeline a little bit Can we spend that money a little bit more wisely and improve some of these outcomes?"

0:45 "Do you want to introduce yourself?"

5:45 "Do you want to describe your job? What do you do and what is the program director do?"

7:45 "Do you want to talk about the Blueprint Initiative?"

9:45 "This sounds almost like a government-led VC, am I off in this?"

11:00 "Do you want to describe the project a little bit?"

13:30 What are some guidelines of the project to fund neurotech companies?

16:30 "Generally, what stage should the company be at?"

18:15 "How do the hubs work? When I think of a hub, I think of a physical, like one location but does it have to be like that?"

23:45 "Do you want to talk a little bit about the motivation for this?"

26:30 "Is there anything that we didn't talk about that you wanted to mention?"

NIH BLUEPRINT MEDTECH LINKS

https://neuroscienceblueprint.nih.gov/neurotherapeutics/blueprint-medtech/blueprint-medtech

-Home website for the Blueprint MedTech program. Overall figure explaining the program on the front page. The site links to the webinars and funding opportunities.

[email protected]

Please reach out if you have any questions!

INDIVIDUAL PROJECT FUNDING OPPORTUNITIES:

October 20, 2021 First receipt date. Multiple receipt dates.

https://grants.nih.gov/grants/guide/pa-files/PAR-21-315.html

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

https://grants.nih.gov/grants/guide/pa-files/PAR-21-282.html

Funding Opportunity TitleBlueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)

INCUBATOR HUBS:

Only 1 receipt date! October 20, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-21-314.html

Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)